PCSK1 and acute kidney injury: Some studies demonstrate that Z-VAD-fmk can increase nephroprotective efficacy of Nec-1 in cisplatin-induced AKI models [160,161]; in contrast, others reported that Z-VAD-fmk shows no more protective effects in mice experience to I/R-driven or iodinated radiocontrast-induced AKI [151,152].